Prosensa

Results: 4



#Item
1RTT / Muscular dystrophy / Medicine / Duchenne muscular dystrophy / Cost / Health / Neuromuscular disease / Medicare / Dystrophy / Clinical medicine / Prosensa

Research Review No. 84. Money, money, money! A recent review. Introduction:

Add to Reading List

Source URL: www.actionduchenne.org

Language: English - Date: 2014-05-22 06:18:00
2Computing / Law / Identity management / Social issues / Social networking service / HTTP cookie / Online Privacy Protection Act / P3P / Criticism of Facebook / Ethics / Privacy / Internet privacy

Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. ("BioMarin") respects the privacy of visitors to its websites and online services and values the confidence o

Add to Reading List

Source URL: www.prosensa.eu

Language: English - Date: 2015-04-27 19:57:39
3Muscular dystrophy / Pharmaceutical sciences / Health / Science / Food and Drug Administration / Clinical trial / Dystrophin / Drug development / Duchenne muscular dystrophy / Pharmacology / Drug discovery / Pharmaceutical industry

Accelerating Access to Treatments of Duchenne CureDuchenne and Prosensa Debra Miller, Founder and CEO, CureDuchenne Celia Economides, Sr Director, IR and Corporate Communications, Prosensa

Add to Reading List

Source URL: www.partneringforcures.org

Language: English - Date: 2014-12-01 15:31:54
4Chemistry / Duchenne muscular dystrophy / Dystrophin / Clinical trial / Methadone / Muscular dystrophy / Health / Biology

Prosensa announces commencement of redosing of drisapersen in North America in patients with Duchenne muscular dystrophy Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), th

Add to Reading List

Source URL: muscle.ca

Language: English - Date: 2014-09-22 14:00:28
UPDATE